Skip to main content

Advertisement

Table 1 Summary of patients’ characteristics

From: Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma

  Urothelial Carcinoma Renal Cell Carcinoma Control
Metastases-free Metastases Metastases-free Metastases
Number of Patients 31 (♂ 22, ♀ 9) 7 (♂ 4, ♀ 3) 50 (♂ 35, ♀ 15) 44 (♂ 30, ♀ 14) 21 (♂ 15, ♀6)
Age 69 [57.5, 73.5] 71 [70.5, 71.5] 65.2 [56.9, 73.2] 63.1 [55.3, 69.2] 66 [61, 73]
TNM classification CIS, Ta, T1–3 N0, M0 Ta, T1–3 N+/M+ T1a-3c N0–1 M0 T1a-4 N0–2 M0–2
Hgb (g/dl) F: 12.9 [10.9, 13.9] M: 13.8 [13.2, 14.4] F: 10.7 [10.6, 11.9] M: 13.8 [12.5, 14.3] F: 13.3 [12.8, 14.4] M: 14.5 [12.8, 15.5] F: 11.6 [10.7, 12.9] M: 14.2 [12.6, 14.7] F: 13.6 [12.9, 14.2] M: 14.9 [14.5, 15.9]
Hepcidin (ng/ml) 36.4 [19.1, 113.3] 59.6 [46.7, 110.8] 8.2 [4, 18.4] 18 [8.3, 35.3] 5.8 [3.9, 11.2]
GDF-15 (pg/ml) 2039.4 [1360.9, 3215.2] 4342.3 [3448, 6406.6] 934.6 [687.1, 1711.2] 1742.6 [989.1, 2690.1] 754.3 [601.3, 987.7]
Relapse 12 5 0 39